Cannabidiol, among other cannabinoid drugs, modulates prepulse inhibition of startle in the SHR animal model: implications for schizophrenia pharmacotherapy by Fernanda Fiel Peres, Fernanda Fiel Peres, Raquel Levin, Raquel Levin, Valéria Almeida, Valéria Almeida, Antonio Waldo Zuardi, Antonio Waldo Zuardi, Jaime E Hallak, Jaime E Hallak, José Alexandre Crippa, José Alexandre Crippa, Vanessa Costhek Abilio, Vanessa Costhek Abilio

Get full text

Is Cannabidiol During Neurodevelopment a Promising Therapy for Schizophrenia and Autism Spectrum Disorders? by Cássio Morais Loss, Cássio Morais Loss, Lucas Teodoro, Gabriela Doná Rodrigues, Lucas Roberto Moreira, Fernanda Fiel Peres, Fernanda Fiel Peres, Antonio Waldo Zuardi, Antonio Waldo Zuardi, José Alexandre Crippa, José Alexandre Crippa, Jaime Eduardo Cecilio Hallak, Jaime Eduardo Cecilio Hallak, Vanessa Costhek Abílio, Vanessa Costhek Abílio

Get full text

Effects of Cannabinoid Drugs on the Deficit of Prepulse Inhibition of Startle in an Animal Model of Schizophrenia: the SHR Strain by Raquel eLevin, Raquel eLevin, Fernanda Fiel Peres, Fernanda Fiel Peres, Valéria eAlmeida, Valéria eAlmeida, Mariana Bendlin Calzavara, Antonio Waldo Zuardi, Antonio Waldo Zuardi, Jaime Eduardo Cecílio Hallak, Jaime Eduardo Cecílio Hallak, José Alexandre Souza Crippa, José Alexandre Souza Crippa, Vanessa Costhek Abílio, Vanessa Costhek Abílio

Get full text

Cannabidiol prevents motor and cognitive impairments induced by reserpine in rats by Fernanda Fiel Peres, Raquel Levin, Mayra Akimi Suiama, Mariana Cepollaro Diana, Douglas Albuquerque Gouvêa, Valéria Almeida, Camila Maurício Santos, Lisandro Lungato, Antonio Waldo Zuardi, Jaime Eduardo Hallak, José Alexandre Crippa, Vânia D'Almeida, Regina H Silva, Vanessa Costhek Abilio

Get full text